November 12, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · DOI: 10.1200/JCO-26-00418

Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras.

Listen to this summary

This population-based cohort study of 7,428 women diagnosed with Hodgkin lymphoma before age 36 in England and Wales (1954–2010) asked whether second cancer risks have declined with modern treatment and what this means for survivorship care. Women had an overall 3.3-fold excess of subsequent cancers, and solid cancer risk fell by 25% in recent treatment eras, a decline largely explained by reduced radiotherapy use and dose, while hematologic malignancy risk did not improve. Elevated risks, particularly for lung and breast cancer, persisted beyond 50 years of follow-up, supporting lifelong surveillance and targeted screening.

Aislinn Macklin-Doherty, David Cunningham, Ian Chau, Andrew Bates, Kim Benstead, Mark Bower, Murray Brunt, Paul Fields, George Follows, Christopher P Fox, John Frew, John G Gribben, Peter Hoskin, Clive Irwin, Lisa Lowry, John Radford, Isabel Syndikus, Anjali Zarkar, Emma Thomas, Amy Berrington de Gonzalez, Michael E Jones, Anthony J Swerdlow

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

More from Journal of clinical oncology : official journal of the American Society of Clinical Oncology

View all →

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.

Nov 17, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.

Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.

Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play